Masimo Total Liabilities and Share Holders Equity 2010-2024 | MASI

Masimo total liabilities and share holders equity for the quarter ending September 30, 2024 was $3.088B, a 3.07% increase year-over-year.

  • Masimo total liabilities and share holders equity for 2023 was $3.042B, a 5.27% decline from 2022.
  • Masimo total liabilities and share holders equity for 2022 was $3.211B, a 70.14% increase from 2021.
  • Masimo total liabilities and share holders equity for 2021 was $1.887B, a 10.19% increase from 2020.

Masimo Total Liabilities and Share Holders Equity 2010-2024 | MASI

  • Masimo total liabilities and share holders equity for 2023 was $3.042B, a 5.27% decline from 2022.
  • Masimo total liabilities and share holders equity for 2022 was $3.211B, a 70.14% increase from 2021.
  • Masimo total liabilities and share holders equity for 2021 was $1.887B, a 10.19% increase from 2020.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$209.2B
Intuitive Surgical (ISRG)$190.8B
Alcon (ALC)$45.5B
IQVIA Holdings (IQV)$39.4B
Edwards Lifesciences (EW)$39.3B
IDEXX Laboratories (IDXX)$35.8B
DexCom (DXCM)$27.5B
Waters (WAT)$22.6B
SONOVA HOLDING (SONVY)$22.1B
STERIS (STE)$21.9B
Hologic (HOLX)$18.4B
Sysmex ADR (SSMXY)$12.9B
Fresenius Medical Care AG KGaA (FMS)$12.6B
Globus Medical (GMED)$11.1B
Penumbra (PEN)$9.3B
Teleflex (TFX)$9.2B
Glaukos (GKOS)$7.9B
PROCEPT BioRobotics (PRCT)$5.1B
Integer Holdings (ITGR)$4.7B
Inari Medical (NARI)$3.1B
Veracyte (VCYT)$3B
TransMedics (TMDX)$3B
LivaNova (LIVN)$2.8B
Nihon Kohden (NHNKY)$2.6B
Elekta AB (EKTAY)$2.3B
Tandem Diabetes Care (TNDM)$2.1B
Integra LifeSciences Holdings (IART)$2B
RxSight (RXST)$1.9B
Alphatec Holdings (ATEC)$1.4B
Artivion (AORT)$1.2B